Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, Italy.
Front Cardiovasc Med
; 10: 1280584, 2023.
Article
en En
| MEDLINE
| ID: mdl-38099229
ABSTRACT
Importance Population studies have recorded an increased, unexplained risk of post-acute cardiovascular and thrombotic events, up to 1 year after acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Objectives:
To search for clinical variables and biomarkers associated with late post-acute thrombotic and cardiovascular events after SARS-CoV-2 infection.Design:
Retrospective cohort study.Setting:
Third-level referral hospital in Bergamo (Italy).Participants:
Analysis of an existing database of adult patients, who received care for SARS-CoV-2 infection at our institution between 20 February and 30 September 2020, followed up on a single date ("entry date") at 3-6 months. Exposure Initial infection by SARS-CoV-2. Main outcomes andmeasures:
Primaryoutcome:
occurrence, in the 18 months after entry date, of a composite endpoint, defined by the International Classification of Diseases-9th edition (ICD-9) codes for at least one of cerebral/cardiac ischemia, venous/arterial thrombosis (any site), pulmonary embolism, cardiac arrhythmia, heart failure. Measures (as recorded on entry date) history of initial infection, symptoms, current medications, pulmonary function test, blood tests results, and semi-quantitative radiographic lung damage (BRIXIA score). Individual clinical data were matched to hospitalizations, voluntary vaccination against SARS-CoV-2 (according to regulations and product availability), and documented reinfections in the following 18 months, as recorded in the provincial Health Authority database. A multivariable Cox proportional hazard model (including vaccine doses as a time-dependent variable) was fitted, adjusting for potential confounders. We report associations as hazard ratios (HR) and 95% confidence intervals (CI).Results:
Among 1,515 patients (948 men, 62.6%, median age 59; interquartile range 50-69), we identified 84 endpoint events, occurring to 75 patients (5%) 30 arterial thromboses, 11 venous thromboses, 28 arrhythmic and 24 heart failure events. From a multivariable Cox model, we found the following significant associations with theoutcome:
previous occurrence of any outcome event, in the 18 months before infection (HR 2.38; 95% CI 1.23-4.62); BRIXIA score ≥ 3 (HR 2.43; 95% CI 1.30-4.55); neutrophils-to-lymphocytes ratio ≥ 3.3 (HR 2.60; 95% CI 1.43-4.72), and estimated glomerular filtration rate < 45â ml/min/1.73â m2 (HR 3.84; 95% CI 1.49-9.91). Conclusions and relevance We identified four clinical variables, associated with the occurrence of post-acute thrombotic and cardiovascular events, after SARS-CoV-2 infection. Further research is needed, to confirm these results.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Front Cardiovasc Med
Año:
2023
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Suiza